Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination

The novel coronavirus (COVID-19) pandemic has caused many deaths worldwide. Managing and diagnosing dermatological conditions has become difficult during this era, especially with the widespread administration of vaccines. We report a 58-year-old man with a history of psoriasis and multiple comorbid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Erick Daniel, Javed, Nismat, Upadhyay, Shubhra, Shekhar, Rahul, Sheikh, Abu Baker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607533/
https://www.ncbi.nlm.nih.gov/pubmed/35256820
http://dx.doi.org/10.1080/08998280.2021.2003681
_version_ 1784602581109047296
author Lopez, Erick Daniel
Javed, Nismat
Upadhyay, Shubhra
Shekhar, Rahul
Sheikh, Abu Baker
author_facet Lopez, Erick Daniel
Javed, Nismat
Upadhyay, Shubhra
Shekhar, Rahul
Sheikh, Abu Baker
author_sort Lopez, Erick Daniel
collection PubMed
description The novel coronavirus (COVID-19) pandemic has caused many deaths worldwide. Managing and diagnosing dermatological conditions has become difficult during this era, especially with the widespread administration of vaccines. We report a 58-year-old man with a history of psoriasis and multiple comorbidities who presented with a worsening pruritic rash 1 week after receiving the COVID-19 Pfizer vaccine. He was treated with triamcinolone-based wet wraps, triamcinolone ointment, and hydroxyzine, which improved his rash significantly after 6 days of hospitalization.
format Online
Article
Text
id pubmed-8607533
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-86075332021-11-23 Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination Lopez, Erick Daniel Javed, Nismat Upadhyay, Shubhra Shekhar, Rahul Sheikh, Abu Baker Proc (Bayl Univ Med Cent) Case Studies The novel coronavirus (COVID-19) pandemic has caused many deaths worldwide. Managing and diagnosing dermatological conditions has become difficult during this era, especially with the widespread administration of vaccines. We report a 58-year-old man with a history of psoriasis and multiple comorbidities who presented with a worsening pruritic rash 1 week after receiving the COVID-19 Pfizer vaccine. He was treated with triamcinolone-based wet wraps, triamcinolone ointment, and hydroxyzine, which improved his rash significantly after 6 days of hospitalization. Taylor & Francis 2021-11-15 /pmc/articles/PMC8607533/ /pubmed/35256820 http://dx.doi.org/10.1080/08998280.2021.2003681 Text en Copyright © 2021 Baylor University Medical Center
spellingShingle Case Studies
Lopez, Erick Daniel
Javed, Nismat
Upadhyay, Shubhra
Shekhar, Rahul
Sheikh, Abu Baker
Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
title Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
title_full Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
title_fullStr Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
title_full_unstemmed Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
title_short Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
title_sort acute exacerbation of psoriasis after covid-19 pfizer vaccination
topic Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607533/
https://www.ncbi.nlm.nih.gov/pubmed/35256820
http://dx.doi.org/10.1080/08998280.2021.2003681
work_keys_str_mv AT lopezerickdaniel acuteexacerbationofpsoriasisaftercovid19pfizervaccination
AT javednismat acuteexacerbationofpsoriasisaftercovid19pfizervaccination
AT upadhyayshubhra acuteexacerbationofpsoriasisaftercovid19pfizervaccination
AT shekharrahul acuteexacerbationofpsoriasisaftercovid19pfizervaccination
AT sheikhabubaker acuteexacerbationofpsoriasisaftercovid19pfizervaccination

Ejemplares similares